Loading...
TriSalus Life Sciences, Inc.
TLSI•NASDAQ
Healthcare
Medical - Devices
$4.56
$-0.11(-2.36%)
TriSalus Life Sciences, Inc. (TLSI) Financial Performance & Income Statement Overview
Review TriSalus Life Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
58.99%
↑ 58.99%
Operating Income Growth
33.21%
↑ 33.21%
Net Income Growth
43.71%
↑ 43.71%
Operating Cash Flow Growth
18.39%
↑ 18.39%
Operating Margin
-99.01%
↓ 99.007%
Gross Margin
85.60%
↑ 85.60%
Net Profit Margin
-84.67%
↓ 84.67%
ROE
103.82%
↑ 103.82%
ROIC
-188.61%
↓ 188.61%
TriSalus Life Sciences, Inc. (TLSI) Income Statement & Financial Overview
Review TriSalus Life Sciences, Inc.'s (TLSI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.26M | $7.35M | $7.36M | $6.46M |
| Cost of Revenue | $1.22M | $1.004M | $912000.00 | $971000.00 |
| Gross Profit | $7.04M | $6.34M | $6.45M | $5.49M |
| Gross Profit Ratio | $0.85 | $0.86 | $0.88 | $0.85 |
| R&D Expenses | $2.96M | $4.22M | $4.67M | $5.86M |
| SG&A Expenses | $11.67M | $10.87M | $9.96M | $11.31M |
| Operating Expenses | $14.63M | $15.08M | $14.63M | $17.17M |
| Total Costs & Expenses | $15.84M | $16.09M | $15.54M | $18.14M |
| Interest Income | $57000.00 | $158000.00 | $97000.00 | $92000.00 |
| Interest Expense | $1.07M | $1.14M | $877000.00 | $3000.00 |
| Depreciation & Amortization | $193000.00 | $169000.00 | $194000.00 | $188000.00 |
| EBITDA | -$8.85M | -$1.01M | -$3.18M | -$13.03M |
| EBITDA Ratio | -$1.07 | -$0.14 | -$0.43 | -$2.02 |
| Operating Income | -$7.58M | -$8.74M | -$8.17M | -$11.69M |
| Operating Income Ratio | -$0.92 | -$1.19 | -$1.11 | -$1.81 |
| Other Income/Expenses (Net) | -$2.53M | $6.34M | $3.85M | -$1.53M |
| Income Before Tax | -$10.11M | -$2.40M | -$4.33M | -$13.22M |
| Income Before Tax Ratio | -$1.22 | -$0.33 | -$0.59 | -$2.05 |
| Income Tax Expense | -$1000.00 | $3000.00 | $7000.00 | $3000.00 |
| Net Income | -$10.11M | -$2.40M | -$4.33M | -$13.22M |
| Net Income Ratio | -$1.22 | -$0.33 | -$0.59 | -$2.05 |
| EPS | -$0.38 | -$0.09 | -$0.18 | -$0.57 |
| Diluted EPS | -$0.38 | -$0.09 | -$0.18 | -$0.57 |
| Weighted Avg Shares Outstanding | $26.50M | $26.50M | $23.90M | $23.32M |
| Weighted Avg Shares Outstanding (Diluted) | $26.50M | $26.50M | $23.90M | $23.32M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan